Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH),...

Full description

Bibliographic Details
Main Authors: Chander K. Negi, Sabbir Khan, Hubert Dirven, Lola Bajard, Luděk Bláha
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/8/4282
id doaj-c2348a9cb2d9491f82cbdceb1c6a9fed
record_format Article
spelling doaj-c2348a9cb2d9491f82cbdceb1c6a9fed2021-04-20T23:04:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01224282428210.3390/ijms22084282Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseChander K. Negi0Sabbir Khan1Hubert Dirven2Lola Bajard3Luděk Bláha4Faculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USADepartment of Environmental Health, Section for Toxicology and Risk Assessment, Norwegian Institute of Public Health, 0456 Oslo, NorwayFaculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicFaculty of Science, RECETOX, Masaryk University, Kamenice 5, CZ62500 Brno, Czech RepublicNonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and eventually leads to hepatic cancer. Several risk factors, including exposure to environmental toxicants, are involved in the development and progression of NAFLD. Environmental factors may promote the development and progression of NAFLD by various biological alterations, including mitochondrial dysfunction, reactive oxygen species production, nuclear receptors dysregulation, and interference in inflammatory and immune-mediated signaling. Moreover, environmental contaminants can influence immune responses by impairing the immune system’s components and, ultimately, disease susceptibility. Flame retardants (FRs) are anthropogenic chemicals or mixtures that are being used to inhibit or delay the spread of fire. FRs have been employed in several household and outdoor products; therefore, human exposure is unavoidable. In this review, we summarized the potential mechanisms of FRs-associated immune and inflammatory signaling and their possible contribution to the development and progression of NAFLD, with an emphasis on FRs-mediated interferon signaling. Knowledge gaps are identified, and emerging pharmacotherapeutic molecules targeting the immune and inflammatory signaling for NAFLD are also discussed.https://www.mdpi.com/1422-0067/22/8/4282flame retardantsnonalcoholic fatty liver diseasemetabolism-disrupting chemicalscytokinesinterferonmetabolic disruption
collection DOAJ
language English
format Article
sources DOAJ
author Chander K. Negi
Sabbir Khan
Hubert Dirven
Lola Bajard
Luděk Bláha
spellingShingle Chander K. Negi
Sabbir Khan
Hubert Dirven
Lola Bajard
Luděk Bláha
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
International Journal of Molecular Sciences
flame retardants
nonalcoholic fatty liver disease
metabolism-disrupting chemicals
cytokines
interferon
metabolic disruption
author_facet Chander K. Negi
Sabbir Khan
Hubert Dirven
Lola Bajard
Luděk Bláha
author_sort Chander K. Negi
title Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
title_short Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
title_full Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
title_fullStr Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
title_full_unstemmed Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease
title_sort flame retardants-mediated interferon signaling in the pathogenesis of nonalcoholic fatty liver disease
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-04-01
description Nonalcoholic fatty liver disease (NAFLD) is a growing concern worldwide, affecting 25% of the global population. NAFLD is a multifactorial disease with a broad spectrum of pathology includes steatosis, which gradually progresses to a more severe condition such as nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and eventually leads to hepatic cancer. Several risk factors, including exposure to environmental toxicants, are involved in the development and progression of NAFLD. Environmental factors may promote the development and progression of NAFLD by various biological alterations, including mitochondrial dysfunction, reactive oxygen species production, nuclear receptors dysregulation, and interference in inflammatory and immune-mediated signaling. Moreover, environmental contaminants can influence immune responses by impairing the immune system’s components and, ultimately, disease susceptibility. Flame retardants (FRs) are anthropogenic chemicals or mixtures that are being used to inhibit or delay the spread of fire. FRs have been employed in several household and outdoor products; therefore, human exposure is unavoidable. In this review, we summarized the potential mechanisms of FRs-associated immune and inflammatory signaling and their possible contribution to the development and progression of NAFLD, with an emphasis on FRs-mediated interferon signaling. Knowledge gaps are identified, and emerging pharmacotherapeutic molecules targeting the immune and inflammatory signaling for NAFLD are also discussed.
topic flame retardants
nonalcoholic fatty liver disease
metabolism-disrupting chemicals
cytokines
interferon
metabolic disruption
url https://www.mdpi.com/1422-0067/22/8/4282
work_keys_str_mv AT chanderknegi flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease
AT sabbirkhan flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease
AT hubertdirven flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease
AT lolabajard flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease
AT ludekblaha flameretardantsmediatedinterferonsignalinginthepathogenesisofnonalcoholicfattyliverdisease
_version_ 1721517182758682624